AVEO Oncology to Present Positive New Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Third- and Fourth-Line Renal Cell Carcinoma
Five year follow-up data show FOTIVDA® (tivozanib) patients up to 5X more likely to experience…
 The Executive Centre Unveils New Premium Flexible Workspace at One IFC, Central Hong Kong
                                                                        The Executive Centre Unveils New Premium Flexible Workspace at One IFC, Central Hong Kong                                 Doubleview Gold Corp Announces Non-Brokered Private Placement of Flow-Through Shares at $1.00 per share along with Non-Flow-Through Units
                                                                        Doubleview Gold Corp Announces Non-Brokered Private Placement of Flow-Through Shares at $1.00 per share along with Non-Flow-Through Units                                 HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus
                                                                        HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus                                 TruMerit’s Peter Preziosi Elected President of the Conference of NGOs in Consultative Relationship With the United Nations
                                                                        TruMerit’s Peter Preziosi Elected President of the Conference of NGOs in Consultative Relationship With the United Nations                                 Decent Cybersecurity Highlights Slovakia’s Tech Leadership at the EU-NZ Business Summit
                                                                        Decent Cybersecurity Highlights Slovakia’s Tech Leadership at the EU-NZ Business Summit